| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 06/28/2023 | Oncternal Therapeutics, Inc. | GTXI | Grant | Stock Options | 25k | $0.36 | $8.9k | | 06/28/2023 |
| 05/26/2023 | DYNAVAX TECHNOLOGIES CORP | DVAX | Grant | | 5.4k | $0.00 | $0 | | 05/26/2023 |
| 05/26/2023 | DYNAVAX TECHNOLOGIES CORP | DVAX | Grant | Stock Option (Right to Buy) | 22.5k | $11.20 | $252k | | 05/26/2023 |
| 06/16/2022 | Oncternal Therapeutics, Inc. | GTXI | Grant | Stock Options | 25k | $1.08 | $27k | | 06/16/2022 |
| 06/14/2022 | Zynerba Pharmaceuticals, Inc. | ZYNE | Grant | Common Stock | 23.1k | $0.00 | $0 | | 06/14/2022 |
| 06/14/2022 | Zynerba Pharmaceuticals, Inc. | ZYNE | Sale | Common Stock | 40 | $1.01 | $40.4 | | 06/14/2022 |
| 06/14/2022 | Zynerba Pharmaceuticals, Inc. | ZYNE | Grant | Stock Option (right to buy) | 34.7k | $1.01 | $35k | | 06/14/2022 |
| 06/01/2022 | Histogen Inc. | CNAT | Grant | | 1000 | $3.20 | $3.2k | | 06/01/2022 |
| 09/02/2021 | Histogen Inc. | CNAT | Grant | Stock Option (right to buy) | 20k | $0.82 | $16.4k | | 09/02/2021 |
| 08/03/2021 | Zynerba Pharmaceuticals, Inc. | ZYNE | Grant | Common Stock | 5k | $0.00 | $0 | | 08/03/2021 |
| 08/03/2021 | Zynerba Pharmaceuticals, Inc. | ZYNE | Grant | Stock Option (right to buy) | 7.5k | $4.44 | $33.3k | | 08/03/2021 |
| 05/28/2021 | DYNAVAX TECHNOLOGIES CORP | DVAX | Grant | Option (Right to Buy) | 25k | $8.20 | $205k | | 05/28/2021 |
| 05/25/2021 | Oncternal Therapeutics, Inc. | GTXI | Grant | Stock Options | 25k | $5.14 | $128.5k | | 05/25/2021 |
| 10/07/2020 | Histogen Inc. | CNAT | Grant | Stock Option (right to buy) | 20k | $1.89 | $37.8k | | 10/07/2020 |
| 07/21/2020 | Oncternal Therapeutics, Inc. | GTXI | Purchase | Common Stock | 10k | $2.38 | $23.8k | By Kisner Revocable Trust | 07/21/2020 |
| 07/21/2020 | Oncternal Therapeutics, Inc. | GTXI | Grant | Warrants | 5k | $2.32 | $11.6k | By Kisner Revocable Trust | 07/21/2020 |
| 06/11/2020 | Oncternal Therapeutics, Inc. | GTXI | Grant | Stock Options | 15k | $2.94 | $44.1k | | 06/11/2020 |
| 06/11/2020 | Oncternal Therapeutics, Inc. | GTXI | Grant | Stock Options | 15k | $2.94 | $44.1k | | 06/11/2020 |
| 06/10/2020 | Zynerba Pharmaceuticals, Inc. | ZYNE | Grant | Stock Option (right to buy) | 15k | $5.21 | $78.2k | | 06/10/2020 |
| 05/28/2020 | DYNAVAX TECHNOLOGIES CORP | DVAX | Grant | Option (Right to Buy) | 25k | $4.84 | $121k | | 05/28/2020 |
| 09/12/2019 | Oncternal Therapeutics, Inc. | GTXI | Grant | Stock Option | 30k | $5.76 | $172.8k | | 09/12/2019 |
| 09/12/2019 | Oncternal Therapeutics, Inc. | GTXI | Grant | Stock Option | 30k | $5.76 | $172.8k | | 09/12/2019 |
| 06/27/2019 | Histogen Inc. | CNAT | Grant | Stock Option (Right to Buy) | 20k | $0.29 | $5.8k | | 06/27/2019 |
| 06/11/2019 | Zynerba Pharmaceuticals, Inc. | ZYNE | Grant | Stock Option (right to buy) | 15k | $13.50 | $202.5k | | 06/11/2019 |
| 05/30/2019 | DYNAVAX TECHNOLOGIES CORP | DVAX | Grant | Option (Right to Buy) | 15k | $4.97 | $74.6k | | 05/30/2019 |
| 06/21/2018 | Histogen Inc. | CNAT | Grant | Stock Option (Right to Buy) | 20k | $4.99 | $99.8k | | 06/21/2018 |
| 06/06/2018 | Zynerba Pharmaceuticals, Inc. | ZYNE | Grant | Stock Option (right to buy) | 15k | $11.30 | $169.5k | | 06/06/2018 |
| 05/31/2018 | DYNAVAX TECHNOLOGIES CORP | DVAX | Grant | Option (Right to Buy) | 15k | $15.80 | $237k | | 05/31/2018 |
| 06/22/2017 | Histogen Inc. | CNAT | Grant | Stock Option (Right to Buy) | 20k | $4.96 | $99.2k | | 06/22/2017 |
| 06/07/2017 | Zynerba Pharmaceuticals, Inc. | ZYNE | Grant | Stock Option (right to buy) | 15k | $18.77 | $281.6k | | 06/07/2017 |
| 06/02/2017 | DYNAVAX TECHNOLOGIES CORP | DVAX | Grant | Option (Right to Buy) | 7.5k | $5.90 | $44.2k | | 06/02/2017 |
| 12/28/2016 | Histogen Inc. | CNAT | Other (acquisition) | Common Stock | 2.3k | $0.00 | $0 | See footnote | 12/28/2016 |
| 06/23/2016 | Histogen Inc. | CNAT | Grant | Stock Option (Right to Buy) | 20k | $2.13 | $42.6k | | 06/23/2016 |
| 05/31/2016 | DYNAVAX TECHNOLOGIES CORP | DVAX | Grant | Option (Right to Buy) | 7.5k | $16.59 | $124.4k | | 05/31/2016 |
| 05/25/2016 | Zynerba Pharmaceuticals, Inc. | ZYNE | Grant | Stock Option (right to buy) | 15k | $7.90 | $118.5k | | 05/25/2016 |
|